Overview Iressa Versus Docetaxel (Taxotere) Status: Completed Trial end date: 2007-10-01 Target enrollment: Participant gender: Summary The purpose of this study is to compare the effects of ZD1839 or docetaxel in patients with advanced non-small cell lung cancer (NSCLC) that has recurred or progressed after receiving prior treatment with platinum-based chemotherapy. Phase: Phase 3 Details Lead Sponsor: AstraZenecaTreatments: DocetaxelGefitinib